Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioFund Management

Founders Kalevi Kurkiju00e4rvi

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 9
Rounds per year 0.44
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 3
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Genetics
  • Life Science
  • Medical Device
  • Health Diagnostics
Summary

In 1997 was created BioFund Management, which is appeared as VC. The venture was found in Europe in Finland. The leading representative office of defined VC is situated in the Helsinki.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BioFund Management, startups are often financed by HBM Healthcare Investments AG, MVI Finance, Biotech Turnaround Fund (BTF). The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Sitra, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Index Ventures, Biofund.

The fund was created by Kalevi Kurkiju00e4rvi. The overall number of key employees were 2.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2014. Opposing the other organizations, this BioFund Management works on 13 percentage points more the average amount of lead investments. The high activity for fund was in 2005. The fund is generally included in less than 2 deals every year.

The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FibroGen, Genizon BioSciences, FIT Biotech.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioFund Management:
Typical Co-investors
BioFund Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioFund Management:

Funds with similar focus

Funds from Finland
Funds with similar focus located in Finland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arthur Rock & Co -
China Super Media Holdings -
Flow Traders Amsterdam, Noord-Holland, The Netherlands
HG Initiative -
Japan startup support Association Ikeda, Japan, Osaka Prefecture
Jiuli Jijin China, Minhang, Shanghai
K Street Capital District of Columbia, United States, Washington
Lu An Industrial China, Guangdong, Shenzhen
NetWorth Partners California, San Diego, United States
NFP Ventures New York, New York, United States
Point King Capital Australia, New South Wales, Sydney
ProVen Private Equity England, London, United Kingdom
Sanko Holding Istanbul, Istanbul, Turkey
Talis Capital England, London, United Kingdom
The Shatter Fund California, San Francisco, United States
Tom Farms -
Xin Ding Capital Beijing, Beijing, China
Yaohong Chuangtou China, Shanghai
Zhongyi Ningbo Ecological Park China, Hebei, Zhongyi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

SpinX

Biotechnology
Health Diagnostics
Life Science
Medical Device
Robotics
$10M06 Sep 2005 Geneva, Geneva, Switzerland

Hyglos

Biopharma
Biotechnology
Developer Platform
Medical
$9M23 Aug 2005 Bernried, Baden-Wurttemberg, Germany

Ipsat Therapies

Biotechnology
Health Diagnostics
Therapeutics
$9M03 Apr 2005 Uusimaa

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$8M13 Dec 2004 Montreal, Quebec, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioFund Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 10M
Rounds per year 0.44
Peak activity year 2005
Lead investments 4
Follow on index 0.18
Exits 3
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

SpinX

Biotechnology
Health Diagnostics
Life Science
Medical Device
Robotics
$10M06 Sep 2005 Geneva, Geneva, Switzerland

Hyglos

Biopharma
Biotechnology
Developer Platform
Medical
$9M23 Aug 2005 Bernried, Baden-Wurttemberg, Germany

Ipsat Therapies

Biotechnology
Health Diagnostics
Therapeutics
$9M03 Apr 2005 Uusimaa

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$8M13 Dec 2004 Montreal, Quebec, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: